Laser-induced nanobubbles for advanced therapies in the eye. Ghent University
Ocular diseases affect the quality of life of millions of patients. Despite some improvements, the arsenal of medications to treat severe ocular diseases today remains rather restricted to traditional drugs. Use of modern biotherapeutics, like proteins and nucleic acids, could be a major step forward. However, current ways of administration, such as eye drops and intravitreal injections, are no longer sufficient to deliver these drugs to most ...